Literature DB >> 6402176

Immunisation of adults during an outbreak of diphtheria.

S R Palmer, A H Balfour, A E Jephcott.   

Abstract

In an outbreak of infection due to Corynebacterium diphtheriae in a hospital for mentally subnormal adults sera from 211 members of staff were screened for diphtheria antitoxin titres. Of these, 79 (37%) required immunisation, and a low dose preparation (1 LfU of diphtheria and 10 LfU tetanus toxoids) was offered. Of the 64 subjects who accepted a single immunisation and were subsequently retested, seroconversion to diphtheria toxoid occurred in 45 (70%), the rate being highest in younger adults. Seroconversion to tetanus toxoid occurred in 59% of subjects. Local reactions to the single dose were reported by 29 (43%) subjects, and nine (13%) experienced moderately severe local reactions and systemic symptoms. We conclude that adults should not be vaccinated without previous screening for susceptibility to diphtheria; that neither previous immunisation nor age is reliable in predicting the need for vaccination; and that though a single booster dose of diphtheria toxoid is probably effective in adults under 45, two doses should be given to those in the older age group.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6402176      PMCID: PMC1546869          DOI: 10.1136/bmj.286.6365.624

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  5 in total

1.  Immunisation of adults against diphtheria.

Authors:  F W Sheffield; A G Ironside; J D Abbott
Journal:  Br Med J       Date:  1978-07-22

2.  Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. I. Studies on factors affecting the toxin and antitoxin titration.

Authors:  K Miyamura; S Nishio; A Ito; R Murata; R Kono
Journal:  J Biol Stand       Date:  1974-07

3.  Side effects of diphtheria-tetanus toxoid in adults.

Authors:  J P Middaugh
Journal:  Am J Public Health       Date:  1979-03       Impact factor: 9.308

4.  Reactions and antibody responses to reinforcing doses of adsorbed and plain tetanus vaccines.

Authors:  L H Collier; S Polakoff; J Mortimer
Journal:  Lancet       Date:  1979-06-30       Impact factor: 79.321

5.  Diphtheria immunization in adolescents and adults with reduced doses of adsorbed diphtheria toxoid.

Authors:  B J Feery; A S Benenson; J R Forsyth; M A Menser; D W Minty
Journal:  Med J Aust       Date:  1981-02-07       Impact factor: 7.738

  5 in total
  7 in total

1.  Statement on vaccination of children with inadequate immunization records.

Authors: 
Journal:  CMAJ       Date:  1990-08-15       Impact factor: 8.262

2.  Boostering antitoxic diphtheria immunity in adults.

Authors:  H M Hasselhorn; F Hofmann; F W Tiller
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

3.  Double-antibody sandwich enzyme-linked immunosorbent assay for rapid detection of toxin-producing Corynebacterium diphtheriae.

Authors:  P B Nielsen; C Koch; H Friis; I Heron; J Prag; J Schmidt
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

4.  Fatal diphtheria in an older woman.

Authors:  C Epp; F Y Aoki
Journal:  Can Med Assoc J       Date:  1985-03-15       Impact factor: 8.262

5.  Immunity to diphtheria and tetanus among blood donors in Arak, central province of Iran.

Authors:  Ali Eslamifar; Amitis Ramezani; Mohammad Banifazl; Masoomeh Sofian; Fatemeh-Alsadat Mahdaviani; Farhad Yaghmaie; Arezoo Aghakhani
Journal:  Iran J Microbiol       Date:  2014-06

Review 6.  Evaluation of Anti-PT Antibody Response after Pertussis Vaccination and Infection: The Importance of Both Quantity and Quality.

Authors:  Alex-Mikael Barkoff; Aapo Knuutila; Jussi Mertsola; Qiushui He
Journal:  Toxins (Basel)       Date:  2021-07-21       Impact factor: 4.546

7.  Preventing the preventable through effective surveillance: the case of diphtheria in a rural district of Maharashtra, India.

Authors:  Revati K Phalkey; Rajesh V Bhosale; Abhijeet P Joshi; Sushil S Wakchoure; Muralidhar P Tambe; Pradip Awate; Michael Marx
Journal:  BMC Public Health       Date:  2013-04-08       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.